Picture of Sage Therapeutics logo

SAGE — Sage Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Sage Therapeutics to discontinue development of Alzheimer’s drug

Oct 8 (Reuters) - Sage Therapeutics  SAGE.O  said on
Tuesday it will discontinue the development of its Alzheimer's
disease drug as it did not meet the main goal in a mid-stage
trial.

 (Reporting by Christy Santhosh; Editing by Pooja Desai)
 ((Christy.Santhosh@thomsonreuters.com;))

Recent news on Sage Therapeutics

See all news